226 related articles for article (PubMed ID: 14654925)
1. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract][Full Text] [Related]
2. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
3. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
[TBL] [Abstract][Full Text] [Related]
4. Expression of soluble, biologically active recombinant human endostatin in Escherichia coli.
Xu HM; Zhang GY; Ji XD; Cao L; Shu L; Hua ZC
Protein Expr Purif; 2005 Jun; 41(2):252-8. PubMed ID: 15866710
[TBL] [Abstract][Full Text] [Related]
5. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
[TBL] [Abstract][Full Text] [Related]
6. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
Dhanabal M; Ramchandran R; Volk R; Stillman IE; Lombardo M; Iruela-Arispe ML; Simons M; Sukhatme VP
Cancer Res; 1999 Jan; 59(1):189-97. PubMed ID: 9892206
[TBL] [Abstract][Full Text] [Related]
7. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
8. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
He GA; Luo JX; Zhang TY; Wang FY; Li RF
Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomes.
Kim KS; Kim HS; Park JS; Kwon YG; Park YS
Cancer Gene Ther; 2004 Jun; 11(6):441-9. PubMed ID: 15118757
[TBL] [Abstract][Full Text] [Related]
11. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
12. Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice.
Li J; Dong X; Xu Z; Jiang X; Jiang H; Krissansen GW; Sun X
J Biomed Sci; 2008 Jan; 15(1):99-109. PubMed ID: 17705027
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of endostatin enhances the efficacy of doxorubicin to suppress human hepatocellular carcinomas in mice.
Liu F; Tan G; Li J; Dong X; Krissansen GW; Sun X
Cancer Sci; 2007 Sep; 98(9):1381-7. PubMed ID: 17627616
[TBL] [Abstract][Full Text] [Related]
14. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
16. Mouse endostatin inhibits the formation of lung and liver metastases.
Yoon SS; Eto H; Lin CM; Nakamura H; Pawlik TM; Song SU; Tanabe KK
Cancer Res; 1999 Dec; 59(24):6251-6. PubMed ID: 10626820
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
[TBL] [Abstract][Full Text] [Related]
18. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
19. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide.
Cao QZ; Lin ZB
Acta Pharmacol Sin; 2004 Jun; 25(6):833-8. PubMed ID: 15169641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
